| Financial Year |
March 31 2023 |
| Monetary Funds |
2,198,633,730.18 |
| Held-for-trading Financial Assets |
31,932,150.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
40,435.18 |
| Advances to Suppliers |
11,819,705.41 |
| Other Receivables |
51,045,181.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
24,997,949.57 |
| Dividend Receivable |
-- |
| Inventories |
205,768,011.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
274,570,795.08 |
| Other Current Assets |
2,119,322.65 |
| Total Current Assets |
2,775,929,331.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,417,862.55 |
| Investment Properties |
7,807,616.67 |
| Fixed Assetes |
358,160,571.07 |
| Under-construction Projects |
1,010,076,125.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,733,128,403.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,019,503.51 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,568,982,082.25 |
| Total Assets |
7,344,911,413.41 |
| Short-Term Loans |
440,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
10,023,226.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,204,541.03 |
| Taxes Payable |
117,391,356.26 |
| Interest Payable |
542,555.91 |
| Dividend Payable |
-- |
| Other payables |
37,885,942.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
195,922,042.23 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
856,961,664.15 |
| Long-term Loans |
621,825,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,682,524,981.33 |
| Special Payable |
-- |
| Estimatied Liabilities |
32,874,942.23 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,389,004,953.85 |
| Total Liabilities |
3,245,966,618.00 |
| Paid-In Capital(Or Share Stock) |
521,171,240.00 |
| Capital Surplus |
1,601,767,342.35 |
| Surplus Reserve |
77,420,429.75 |
| LESS:Treasury Stock |
9,289,280.00 |
| Undistributed Profits |
781,734,441.76 |
| Minority Stockholder's Interest |
1,120,958,259.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,977,986,535.96 |
| Owner's Equity（Stockholder's Equity） |
4,098,944,795.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,344,911,413.41 |
